Advertising
Showing 1 to 15 of 23 entries
PAST TOP PICK
(A Top Pick Aug 06/21, Down 15%) Frustrating stock move movement because it is in healthcare and is the second largest producer of endoscopes and eye glass lenses. However the market is gravitating towards pharmaceutical. Also a smaller part is tied to the tech space which is doing well and could be doing even better when techs improve. He is a long term holder but doesn't know the long term catalysts.
Healthcare
PAST TOP PICK
(A Top Pick Apr 14/21, Down 6%) It is a world leader in production of low cost eyeglasses. It also produces components in semi-conductors. He is disappointed in the short term price of the stock but the long term prospects are good,
Healthcare
BUY on WEAKNESS
Very good longer term. Reasonable balance sheet. Shareholder support is quite good. Reasonable returns. Beneficiary of semiconductor business. With volatility, stock probably moves further south, so chance to pick it up lower. Be aware that Japan's central bank is playing in the currency market to support the yen.
Healthcare
COMMENT
Second largest producer of eye glasses and other glass products such as endoscopes, etc. Very high quality company with strong margins and long term record of growth. There is growth opportunity in eye glasses. Endoscope area could present a challenge with possible switch to disposable technology. Stewards of capital eg. dividend growth. An entrepreneurial company, one of the best in Japan.
Healthcare
TOP PICK
The price target is in Japanese yen. Expertise is in glass. There is pent-up demand in eye glasses. They are number 2 in the world. They are also a producer of a substrate for hard disk platters. They also dominate the photo lithography for semiconductors. A play on the extreme ultraviolet lithography. (Analysts’ price target is $16600.00)
Healthcare
PAST TOP PICK
(A Top Pick Apr 07/20, Up 43%) Produce endoscopes, eyeglass lenses, glass platters for hard disks, and leading edge nodes. A long-term favourite.
Healthcare
TOP PICK
Lots of pent-up demand for eyeglass lenses and endoscopy procedures. Pent-up demand is one of his themes for the early stage of an economic recovery. (Price target is in yuan.) Yield is 0.65%. (Analysts’ price target is $14486.36)
Healthcare
BUY
Hard drives refuse to die. Hoya is the only supplier of glass platters, so that's where he's invested. Hard drives will be transitioning from aluminum to glass over the next 5 years.
Healthcare
PAST TOP PICK
(A Top Pick Dec 02/19, Up 40%) Masters of making glass. Second largest eye glass lens maker in the world. Their Pentax lens unit will benefit from pent-up demand in endoscopy. Well positioned in current environment.
Healthcare
PAST TOP PICK
(A Top Pick Aug 02/19, Up 26%) They have cyclical upside in their medical technology business, so pent-up demand from hospitals in a tailwind. Same goes with their eyeglass division as people now get their eyes examined after the lockdown.
Healthcare
TOP PICK
Price target: 10,237 Yen The second-biggest maker of eyeglass lenses and a low-cost producer. He expects Hoya to take market share. It's also the world's second-biggest maker of endoscopes which will be used in selective procedures return post-lockdown. Hoya has been doing well, given its monopoly in photomasks used in lithography. Also are the only producer of glass used in hard-disk platters which helps transfer more data in a hard disc, which are seeing high demand.
Healthcare
PAST TOP PICK
(A Top Pick Mar 25/19, Up 43%) They make endoscopes. They handle glass, their specialty. It's a Japanese company, but are unusual for Japan because they focus on ROE and are highly entrepreneurial.
Healthcare
TOP PICK
11,027 Yen price target Also a past pick today. Competitor
Healthcare
TOP PICK
They make glass. Eye glasses. They have been buying up competitors. (Analysts’ price target is $9621.58)
Healthcare
TOP PICK
A Japanese company and one of the world's biggest producers in making eyeglass lenses. Also, are the second-largest producer of endoscopes used for minimally invasive surgery which is a trend. (Analysts’ price target is $76.45)
Healthcare
Showing 1 to 15 of 23 entries

Hoya Corporation(7741-JP) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for Hoya Corporation is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Hoya Corporation(7741-JP) Frequently Asked Questions

What is Hoya Corporation stock symbol?

Hoya Corporation is a OTC stock, trading under the symbol 7741-JP on the (). It is usually referred to as or 7741-JP

Is Hoya Corporation a buy or a sell?

In the last year, 3 stock analysts published opinions about 7741-JP. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Hoya Corporation.

Is Hoya Corporation a good investment or a top pick?

Hoya Corporation was recommended as a Top Pick by on . Read the latest stock experts ratings for Hoya Corporation.

Why is Hoya Corporation stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Hoya Corporation worth watching?

3 stock analysts on Stockchase covered Hoya Corporation In the last year. It is a trending stock that is worth watching.

What is Hoya Corporation stock price?

On 2019-10-22, Hoya Corporation (7741-JP) stock closed at a price of $9176.